AI Medical Content Specialist
An AI Medical Content Specialist creates, curates, and validates clinically accurate health content at scale using large language …
Skill Guide
The systematic process of evaluating the truthfulness, reliability, and clinical applicability of medical claims by applying standardized evidence grading systems like GRADE (Grading of Recommendations, Assessment, Development and Evaluations) and the Oxford Centre for Evidence-Based Medicine (CEBM) Levels of Evidence.
Scenario
You are given the abstract of a newly published randomized controlled trial (RCT) claiming a new drug lowers blood pressure more effectively than the standard care.
Scenario
You are provided with a Cochrane systematic review on the efficacy of a surgical intervention for chronic pain. You must create a GRADE evidence profile for the primary outcome.
Scenario
A major health news outlet publishes a story based on a compelling observational study (Oxford Level 4) linking a supplement to reduced dementia risk. Your organization's internal fact-check flags it. You must draft an internal memo reconciling this with the existing body of evidence, which includes multiple Level 1 systematic reviews showing no effect.
GRADE is the gold standard for rating certainty of evidence and strength of recommendations. Oxford CEBM provides a quick hierarchical classification for study types. Use GRADE for formal guideline development and Oxford CEBM for rapid initial assessment.
These structured tools guide the step-by-step evaluation of a single study's methodology and bias. They operationalize the 'risk of bias' domain within GRADE and are essential for rigorous, reproducible appraisals.
Cochrane Library is the premier source for high-quality systematic reviews. PubMed Clinical Queries filters for clinically relevant studies. These sources provide the primary material for evidence grading and are used to find the highest available evidence on a topic.
Answer Strategy
The candidate must demonstrate they can move beyond a simplistic 'RCT vs. cohort' comparison and apply structured reasoning. The strategy is to: 1) Acknowledge the initial observational study's strength (large N, consistent) but flag its critical limitation (confounding, no randomization). 2) Critique the RCT's post-hoc analysis (potential lack of power for a rare event, secondary outcome). 3) Apply GRADE: Start with 'low' certainty for the observational evidence (rating down for indirectness if the RCT population differs, and risk of bias). Conclude that the overall certainty in the drug's liver injury risk is 'low' or 'very low'. The answer should emphasize the need for pharmacovigilance and not dismissing the signal, but clearly communicating the uncertain evidence base to clinicians and patients.
Answer Strategy
This tests the ability to apply evidence grading to real-world content pressure. The core competency is explaining the profound disconnect between the claim and the evidence strength. A professional response would: 1) Immediately classify the study as Oxford CEBM Level 4 (case series). 2) Highlight fatal flaws: no control group (open-label), high risk of bias, tiny sample size, short duration, and subjective outcome measures. 3) Explain that GRADE would rate the certainty of any treatment effect as 'very low'. 4) Conclude that the headline is grossly misleading and recommend either killing the story or reframing it as a very early, preliminary finding that is insufficient to support any therapeutic claim.
1 career found
Try a different search term.